Pediatric Solid Tumor Program
The solid tumor treatment group provides outstanding care for children with cancer by combining the expertise of specialists in related disciplines with an intensely collaborative treatment approach. It's one of the few pediatric cancer programs in the country with a team dedicated to solid tumors. Families benefit from having experts for every type of solid tumor developing a treatment plan that is specific to each child.
Our specialists include:
- Medical oncologists who are well-versed in the most current data and aware of the most recent innovations
- Expert pediatric surgeons with a extensive experience in all types of pediatric cancers
- Radiation oncologists with cutting-edge technology and extensive experience
Our practice approach
A core group of six attending pediatric oncologists teams with fellows and oncology nurse practitioners to treat children with solid tumors (including newly diagnosed neuroblastoma).
The core group develops comprehensive treatment plans and is supported by an additional four attending oncologists who join them in treating patients with solid tumors on the inpatient service.
Patients who receive solid tumor treatment at CHOP typically see members of the core group each time so they can build a relationship with their caregivers and their caregivers can get to know them well.
In addition to the individual attention patients receive from their primary oncologists, they benefit from the collective expertise of the entire solid tumor treatment group. The full treatment group remains actively involved in the oversight of every patient's care, discussing patients' needs and treatment on a regular basis:
- Each week, the team of physicians, nurses, nurse practitioners, social workers, case manager, outpatient schedule and clinical research assistants reviews the list of patients currently on therapy. They make plans for the upcoming week and month and troubleshoot all patient care issues.
- At the time of diagnosis and at key decision points, the team discusses patients in a formal multidisciplinary solid tumor conference and the entire group provides extensive input to help the primary oncologists reach their decisions.
Our research
Areas of research focus for the solid tumor treatment group include:
- Clinical trials of agents for patients whose cancers don't respond to initial or established treatments
- Clinical trials of new anti-cancer drugs
- Novel treatments that have not previously been administered to children
See all clinical trials available at the Cancer Center.
Appointments
To make an appointment or to request a second opinion consultation at the Cancer Center, please call 215-590-2810.
Learn more about second opinions at the Cancer Center
Meet Our Team
Solid tumor physician team
- Rochelle Bagatell MD
- Frank Balis MD
- Naomi Balamuth MD
- Elizabeth Fox MD
- Michael Hogarty MD
- Richard Womer MD
Oncologists who treat patients with solid tumors while in the hospital
Surgical oncology - ENT
Surgical oncology - General
- N. Scott Adzick MD, MMM, FAAP, FACS
- Thane Blinman MD
- Joy Collins MD, FAAP
- Edward Doolin MD, FAAP, FACS
- Alan Flake MD, FACS, FAAP
- Holly Hedrick MD, FAAP, FACS
- Peter Mattei MD, FAAP, FACS
- Michael Nance MD, FAAP, FACS
Surgical oncology - Liver
Surgical oncology - Neurosurgery
Surgical oncology - Oral-maxillofacial
Surgical oncology - Urological
- Douglas Canning MD
- Michael Carr MD, PhD
- Pasquale Casale MD
- N. Scott Adzick MD, MMM, FAAP, FACS
- Howard Snyder MD
- Stephen Zderic MD
Contact Us
Existing patients or family members, please call
215-590-2810
To schedule an initial appointment or request a 2nd opinion
267-426-0762